Please login to the form below

Not currently logged in
Email:
Password:

Incisive Health appoints new director

Jean-Louis Roux joins the firm from EURORDIS

Incisive_Health_Jean_Louis_RouxIncisive Health has appointed Jean-Louis Roux as its new director to support the consultancy’s international business.

Previously serving the European Organisation for Rare Diseases (Eurordis) as its public affairs director, Roux has experience in leading firm’s engagement with European and international policy-makers.

He said: “The international health community faces real challenges, with distracted decision makers increasingly turning inwards.

“Having observed Incisive Health’s first steps on the international stage, I am impressed by the way the team combines real expertise and creativity at a time when both are clearly needed.

“I can’t wait to play my part in the next stage of Incisive Health International.”

With over 12 years of healthcare public affairs experience, acquired in corporate, NGO and consultancy environments,

Prior to his time at EURORDIS, Roux has previously worked for Bristol-Myers Squibb (BMS) in its Global Policy Advocacy and Government Affairs group.

Mike Birtwistle, founding partner of Incisive Health, said: “The appointment of Jean-Louis marks the next stage in our international development.

“We envisage a series of international hires to further bolster our offer in the coming months.”

5th April 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics